These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7013666

  • 1. Amyloidosis.
    Gorevic PD, Franklin EC.
    Annu Rev Med; 1981; 32():261-71. PubMed ID: 7013666
    [No Abstract] [Full Text] [Related]

  • 2. [Amyloidosis in patients with rheumatoid arthritis].
    Bluszcz-Roznowska A, Kucharz EJ.
    Przegl Lek; 2005; 62(12):1532-7. PubMed ID: 16786790
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Secondary amyloidosis associated with rheumatoid arthritis (RA)].
    Koseki Y, Goto M.
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():278-82. PubMed ID: 15799361
    [No Abstract] [Full Text] [Related]

  • 5. [Amyloidosis: protein thesaurismosis].
    Tena X, Olivé A.
    Med Clin (Barc); 1994 Sep 24; 103(9):348-56. PubMed ID: 7967897
    [No Abstract] [Full Text] [Related]

  • 6. [Secondary amyloidosis in patients with rheumatoid arthritis(RA)].
    Inada S.
    Nihon Rinsho; 2002 Dec 24; 60(12):2417-22. PubMed ID: 12510371
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT, Westermark P.
    FEBS Lett; 2009 Aug 20; 583(16):2685-90. PubMed ID: 19393650
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic options in systemic AL amyloidosis.
    van Gameren II, Lokhorst H, Hazenberg BP, Vellenga E.
    Neth J Med; 2004 Apr 20; 62(4):106-13. PubMed ID: 15255079
    [Abstract] [Full Text] [Related]

  • 10. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
    Maury CP, Wegelius O.
    Int J Tissue React; 1985 Apr 20; 7(5):405-7. PubMed ID: 4055265
    [Abstract] [Full Text] [Related]

  • 11. The cutaneous amyloidoses. Pathogenesis and therapy.
    Breathnach SM.
    Arch Dermatol; 1985 Apr 20; 121(4):470-5. PubMed ID: 3883907
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Current theories on the pathogenesis of amyloidosis].
    Kordecki H.
    Wiad Lek; 1982 Oct 15; 35(18):1171-6. PubMed ID: 6817524
    [No Abstract] [Full Text] [Related]

  • 14. [Secondary (AA) amyloidosis].
    Komatsuda A, Miura AB.
    Ryoikibetsu Shokogun Shirizu; 1998 Oct 15; (22 Pt 3):488-91. PubMed ID: 9851197
    [No Abstract] [Full Text] [Related]

  • 15. [Amyloidosis].
    Moszczyński P.
    Pieleg Polozna; 1984 Oct 15; (10):16-7. PubMed ID: 6570234
    [No Abstract] [Full Text] [Related]

  • 16. Systemic amyloidosis: a clinical survey of 144 cases.
    Janssen S, Van Rijswijk MH, Meijer S, Ruinen L, Van der Hem GK.
    Neth J Med; 1986 Oct 15; 29(11):376-85. PubMed ID: 3808140
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A case of primary systemic amyloidosis with AA protein.
    Okada K, Takahashi S, Horiuchi K, Nagura Y, Hatano M.
    Nihon Jinzo Gakkai Shi; 1991 May 15; 33(5):529-31. PubMed ID: 1895552
    [Abstract] [Full Text] [Related]

  • 20. Amyloid proteins, precursors, mediator, and enhancer.
    Cohen AS, Shirahama T, Sipe JD, Skinner M.
    Lab Invest; 1983 Jan 15; 48(1):1-4. PubMed ID: 6401828
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.